| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.93M | 57.72M | 53.67M | 50.38M | 37.86M | 31.81M |
| Gross Profit | 59.32M | 51.76M | 48.59M | 46.10M | 34.13M | 30.32M |
| EBITDA | -25.87M | -24.83M | -28.52M | -25.33M | -20.27M | -1.25M |
| Net Income | -34.45M | -33.64M | -36.87M | -27.39M | -23.38M | -3.26M |
Balance Sheet | ||||||
| Total Assets | 107.74M | 106.14M | 102.80M | 115.52M | 120.44M | 42.74M |
| Cash, Cash Equivalents and Short-Term Investments | 39.08M | 43.84M | 41.17M | 68.15M | 85.83M | 11.74M |
| Total Debt | 6.86M | 5.99M | 7.75M | 3.62M | 3.91M | 4.77M |
| Total Liabilities | 119.19M | 107.32M | 87.70M | 77.98M | 67.54M | 49.03M |
| Stockholders Equity | -11.45M | -1.19M | 15.10M | 37.53M | 52.90M | -6.30M |
Cash Flow | ||||||
| Free Cash Flow | -372.00K | -1.04M | -17.23M | -7.82M | -1.62M | 1.51M |
| Operating Cash Flow | 932.00K | -720.00K | -15.73M | -6.77M | -814.00K | 2.16M |
| Investing Cash Flow | -2.98M | 970.00K | -4.69M | -37.48M | -1.36M | -5.15M |
| Financing Cash Flow | 1.69M | -262.00K | -2.92M | -4.15M | 76.25M | 790.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $314.27M | 22.74 | 22.20% | 6.13% | -9.48% | -14.28% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
53 Neutral | $1.14B | ― | -45.62% | ― | -44.30% | 16.42% | |
52 Neutral | $652.64M | ― | ― | ― | 20.45% | 12.28% | |
51 Neutral | $624.76M | ― | -4.22% | ― | 5.55% | -239.94% | |
51 Neutral | $169.15M | ― | -24.56% | ― | 8.70% | -13.95% | |
39 Underperform | $354.88M | ― | ― | ― | ― | -3299.52% |
Arteris, Inc. recently held its earnings call, revealing a balanced sentiment of strong performance and ongoing financial challenges. The company celebrated record contract values and increased product adoption, particularly in the AI and automotive sectors, while also acknowledging hurdles such as operating losses and delayed royalty revenue realization.
Arteris, Inc. is a prominent player in the semiconductor industry, specializing in system IP that enhances the development of high-performance, energy-efficient silicon chips. The company is known for its network-on-chip (NoC) interconnect IP and SoC integration automation software, catering to leading semiconductor and technology firms globally.
Arteris, Inc. faces a multitude of business risks that could significantly impact its financial health and operational success. The company is challenged by intense competition from larger entities and third-party providers, which may develop their own IP solutions, potentially reducing demand for Arteris’s offerings. Additionally, the company’s reliance on the acceptance of its semiconductor IP solutions by various market sectors, coupled with its history of net losses, underscores the uncertainty of achieving sustained profitability. Furthermore, Arteris’s dependence on international operations exposes it to regulatory and political risks, while its ongoing need for substantial R&D investment could strain financial resources, especially if anticipated revenues do not materialize.
Arteris, Inc. recently held its earnings call, revealing a generally positive sentiment with strong revenue growth and strategic customer wins, such as a significant agreement with AMD. However, the company also faced challenges, including increased operating expenses and negative free cash flow, influenced by foreign exchange impacts.
Arteris, Inc. is a prominent provider of semiconductor system IP, specializing in accelerating the creation of system-on-chip (SoC) designs for high-performance and power-efficient silicon, serving leading semiconductor and technology companies globally. In its latest earnings report, Arteris announced a record Annual Contract Value plus royalties of $69.1 million for the second quarter of 2025, alongside a 13% year-over-year increase in revenue to $16.5 million. The company also reported a net loss of $9.1 million, or $0.22 per share, reflecting ongoing investments in research and development and sales and marketing efforts. Key highlights from the quarter include strategic partnerships and product innovations, such as AMD licensing Arteris’ FlexGen smart network-on-chip IP and the introduction of Magillem Packaging software to streamline chiplet and SoC assembly. Looking ahead, Arteris remains optimistic about its growth prospects, supported by a robust product portfolio and strong industry partnerships, as it continues to target high-growth markets like AI, autonomous driving, and advanced communications.